Introduction
Preeclampsia is caused by abnormal placental development early in pregnancy, followed by a maternal vascular and inflammatory response that disrupts normal blood pressure control and organ function. It is not produced by a single defect. Instead, it develops through a chain of biological events involving the placenta, the maternal blood vessels, the immune system, and the balance of signaling molecules that regulate vascular tone and endothelial health. The main contributors include impaired placentation, abnormal immune adaptation to pregnancy, inherited susceptibility, and maternal conditions that make the cardiovascular system less able to compensate for pregnancy-related stress.
To understand why preeclampsia occurs, it helps to separate the process into its major components. The first is the formation of the placenta and its blood supply. The second is the maternal response to placental dysfunction, especially widespread damage to the endothelium, the thin layer of cells lining blood vessels. The third is the way genetic, metabolic, and environmental factors increase the likelihood that these processes will become abnormal.
Biological Mechanisms Behind the Condition
In a normal pregnancy, cells from the developing placenta invade the lining of the uterus and remodel the maternal spiral arteries. This remodeling turns small, muscular vessels into low-resistance channels that can deliver large volumes of blood to the placenta. The placenta then receives a steady, high-flow supply of oxygen and nutrients for the fetus. In preeclampsia, this remodeling is incomplete or abnormal. The spiral arteries remain relatively narrow and reactive, so the placenta is exposed to reduced blood flow and intermittent episodes of low oxygen.
That reduced perfusion is important because it causes placental stress. A stressed placenta releases substances into the maternal circulation that alter vascular function. Among the most important are antiangiogenic factors, such as soluble fms-like tyrosine kinase-1, which binds and reduces the activity of vascular growth signals needed to maintain healthy blood vessels. The result is endothelial dysfunction. Blood vessels become more constricted, more permeable, and more likely to trigger clotting and inflammation. This helps explain why preeclampsia can affect multiple organ systems, including the kidneys, liver, brain, and placenta itself.
The endothelial injury also shifts the balance of vasoactive mediators. Normally, pregnancy favors vasodilation through nitric oxide and other relaxing factors. In preeclampsia, vasoconstrictors and inflammatory mediators become more dominant, increasing systemic vascular resistance and blood pressure. At the same time, the kidneys may lose the ability to retain protein within the blood because the glomerular endothelium is damaged. This contributes to proteinuria, one of the classic signs of the disorder. The same vascular injury can also reduce blood flow to the brain or liver and contribute to headache, visual disturbance, upper abdominal pain, or more severe complications.
Primary Causes of Preeclampsia
Abnormal placental implantation is the central cause most strongly linked to preeclampsia. During early pregnancy, trophoblast cells from the placenta should invade deeply enough to transform the maternal spiral arteries. If this invasion is shallow or incomplete, the placenta remains underperfused. The placenta then becomes a source of oxidative stress and inflammatory signaling. This process does not directly “create” hypertension at the outset; rather, it produces the upstream placental dysfunction that later drives the maternal syndrome.
Defective placental angiogenesis is another major cause. The placenta needs a carefully regulated network of blood vessels. When the balance between proangiogenic and antiangiogenic factors is disturbed, the placenta cannot maintain a healthy vascular interface. Elevated antiangiogenic proteins in maternal blood interfere with endothelial maintenance and vessel repair. This contributes to vasoconstriction, capillary leakage, and the widespread vascular instability that defines the condition.
Maternal endothelial susceptibility also plays a direct role. Some pregnant individuals have blood vessels that respond more strongly to inflammatory and vasoconstrictive signals. If the maternal endothelium is already stressed by chronic hypertension, obesity, kidney disease, diabetes, or other vascular conditions, it is less able to tolerate the placental signals that provoke preeclampsia. In this setting, the same placental abnormality can produce a more pronounced maternal syndrome.
Immune maladaptation between mother and placenta is a further primary mechanism. Pregnancy requires the maternal immune system to tolerate a genetically distinct placenta and fetus while still defending against infection. If immune recognition at the maternal-fetal interface is abnormal, placental invasion and vascular remodeling can be impaired. In particular, mismatches in immune signaling may reduce the ability of placental cells to establish proper contact with maternal tissues, increasing the likelihood of placental ischemia and downstream endothelial dysfunction.
Contributing Risk Factors
Genetic influences are among the most important contributors to preeclampsia risk. A family history of the condition raises the likelihood that a person carries inherited variants affecting placental invasion, immune recognition, coagulation, or vascular regulation. These genetic factors do not act as a single cause; instead, they alter how the maternal and placental systems respond to pregnancy. Different gene combinations can influence susceptibility to endothelial injury, oxidative stress, and abnormal inflammatory signaling.
Environmental exposures may also contribute biologically. Long-term exposure to air pollution, smoking-related toxins, chronic psychosocial stress, or limited access to prenatal care can affect vascular health and inflammatory tone. Such exposures may not directly cause preeclampsia on their own, but they can impair endothelial function or increase baseline inflammation, making placental dysfunction more likely to trigger a clinical syndrome. Nutritional factors may matter as well, particularly when they influence oxidative balance, calcium status, or metabolic health.
Infections have been investigated as possible contributors because immune activation and systemic inflammation can worsen endothelial function. Although infection is not a universal cause, inflammatory responses to infection can amplify the vascular instability that preeclampsia depends on. The biological link is not simply the presence of microbes, but the host response: cytokines, acute-phase reactants, and immune activation can interact with placental stress and worsen maternal vascular reactivity.
Hormonal changes are another relevant factor. Pregnancy itself is a major hormonal state, and the balance of estrogen, progesterone, placental hormones, and renin-angiotensin system activity changes substantially. In preeclampsia, these regulatory systems may become dysregulated. For example, altered sensitivity to angiotensin II can increase vasoconstriction even when circulating hormone levels are not dramatically elevated. Hormonal effects therefore contribute to blood pressure instability and the reduced ability of blood vessels to adapt normally to pregnancy.
Lifestyle factors can also increase risk through their effects on cardiovascular and metabolic reserve. Obesity, low physical activity, poor metabolic control, and excessive sodium sensitivity may all intensify inflammation, insulin resistance, and vascular dysfunction. These factors do not act in a simple linear way. Instead, they change the background state of the maternal circulation, making it easier for placental signals to push the system into preeclampsia.
How Multiple Factors May Interact
Preeclampsia often emerges when several weak points align. A placenta with incomplete vascular remodeling may generate ischemic stress. If the mother also has a predisposition to endothelial dysfunction, the circulating antiangiogenic and inflammatory factors from the placenta will produce greater vascular damage. If metabolic disease, obesity, or chronic hypertension are present, the maternal system starts from a less resilient baseline. The combination of placental stress plus reduced vascular reserve can cross a threshold that a single factor alone would not reach.
These interactions help explain why the condition can appear sudden even though the underlying processes develop gradually. The placenta may begin to function abnormally weeks earlier, but the maternal circulation may compensate for a time. Once compensatory mechanisms fail, blood pressure rises and organ-specific symptoms appear more quickly. In this sense, preeclampsia is not simply the result of “high blood pressure in pregnancy”; it is the end stage of a multi-system failure in placental signaling, vascular adaptation, and immune regulation.
Variations in Causes Between Individuals
The relative importance of each cause differs from one person to another. In some pregnancies, placental implantation defects are dominant, with little evidence of pre-existing maternal vascular disease. In others, maternal factors such as chronic hypertension, diabetes, kidney disease, or obesity may play a larger role in lowering the threshold for disease. Genetic background also affects how strongly an individual responds to placental stress, which is one reason preeclampsia can run in families but still vary widely in severity.
Age can shape the risk profile as well. Very young or older pregnant individuals may have different vascular and immune reserves, which can influence how well the body adapts to pregnancy. Prior health status matters because preeclampsia develops against the background of the cardiovascular system that already exists. Someone with healthy vessels and normal renal function may tolerate pregnancy-related circulatory changes better than someone with chronic disease or long-standing inflammation.
Environmental exposure differs too. Two individuals with similar genetic risk may have very different outcomes depending on nutrition, stress load, air quality, medical access, and baseline cardiometabolic health. These differences do not change the core biology of preeclampsia, but they alter how easily that biology is triggered and how severe the response becomes.
Conditions or Disorders That Can Lead to Preeclampsia
Several medical conditions are associated with a higher likelihood of preeclampsia because they affect the blood vessels, kidneys, or metabolic systems involved in pregnancy adaptation. Chronic hypertension is one of the strongest associations. If blood vessels are already under pressure before pregnancy, the additional demands of placental circulation can overwhelm the system more easily. The endothelium is less flexible, the arteries are less able to remodel, and placental perfusion may be reduced from the start.
Kidney disease is another important contributor. The kidneys help regulate blood pressure, fluid balance, and vascular hormones. When renal function is impaired, the maternal body may have difficulty handling the increased circulatory load of pregnancy. Kidney disease also makes it harder to distinguish normal adaptation from early vascular injury, and it can amplify protein loss and hypertension when preeclampsia begins.
Diabetes, especially when poorly controlled, increases risk through multiple pathways. Elevated glucose damages blood vessels, promotes oxidative stress, and worsens inflammation. These effects can interfere with placental implantation and endothelial stability. Diabetes is also associated with broader metabolic dysfunction, which makes pregnancy-related vascular stress harder to compensate for.
Autoimmune disorders such as lupus or antiphospholipid syndrome can contribute through immune-mediated vascular injury and abnormal clotting. In these conditions, the maternal immune system is already prone to attack tissues or form pathogenic antibodies. Because preeclampsia depends partly on immune and endothelial dysfunction, autoimmune disease can raise risk by intensifying the same pathways. Clotting abnormalities may also impair placental blood flow, creating a stronger ischemic trigger.
Multiple gestation, such as twins or higher-order pregnancies, is another condition associated with preeclampsia. The placenta burden is greater, and the demand for vascular remodeling is more complex. A larger placental mass can release more circulating factors, increasing the likelihood that the maternal endothelium will be stressed beyond its capacity.
Conclusion
Preeclampsia develops because placental blood vessel remodeling goes wrong and the resulting placental stress provokes a maternal vascular response. The key biological events are impaired implantation, reduced placental perfusion, release of antiangiogenic and inflammatory factors, and widespread endothelial dysfunction. Genetics, immune adaptation, metabolic health, chronic vascular disease, environmental exposures, and hormonal regulation all shape how likely these processes are to occur and how severe they become.
Understanding the causes of preeclampsia means understanding it as a disorder of placental biology and maternal vascular response, not as a single isolated symptom or one-factor illness. The condition arises when several systems fail to adapt together, which is why the same pregnancy disorder can look different from one person to another and why its causes are often shared between the placenta, the mother, and the broader biological environment.